U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Combination Products
  3. Jurisdictional Information
  4. RFD Jurisdictional Decisions
  1. Jurisdictional Information

RFD Jurisdictional Decisions

Transparency in the jurisdictional decision making process is a goal of FDA. Accordingly, FDA is providing redacted RFD decision letters and capsular descriptions of jurisdictional determinations for products that have been approved (refer to web pages listed below). Such transparency in jurisdictional decision making should result in greater predictability and consistency of decisions, and decrease ambiguity and uncertainty about FDA perspectives. Moreover, as the bases for FDA decision making become clearer, the need for formal RFD’s and informal inquiries covering specific products may be diminished, which should conserve resources for both industry and FDA.

Capsular Descriptions of Jurisdictional Determinations

Redacted Decision Letters

 



Back to Top